Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention DelveInsight Business Research LLP, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Minimally Invasive Surgical Devices, all published on March 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Minimally Invasive Surgical Devices
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention DelveInsight Business Research LLP, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Minimally Invasive Surgical Devices, all published on March 11, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Minimally Invasive Surgical Devices. Shared-story counts are live from our verified record — not editorial picks.
The global minimally invasive surgical devices market is projected to grow at a 7% CAGR through 2034, driven by technological advancements and a shift toward outpatient care. This growth reflects a broader healthcare transition prioritizing reduced recovery times and improved patient outcomes.
Minimally Invasive Surgical Devices is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.